|
DDX10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.70329999999086E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.13299999995975E-06 |
| Normal-vs-Stage2 |
8.6480000005551E-07 |
| Normal-vs-Stage3 |
9.24360032961147E-10 |
| Normal-vs-Stage4 |
5.10919995200254E-09 |
| Stage1-vs-Stage2 |
4.771200E-01 |
| Stage1-vs-Stage3 |
9.889700E-02 |
| Stage1-vs-Stage4 |
1.401040E-01 |
| Stage2-vs-Stage3 |
4.730000E-01 |
| Stage2-vs-Stage4 |
5.251000E-01 |
| Stage3-vs-Stage4 |
9.412000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.59819999854005E-08 |
| Normal-vs-AfricanAmerican |
1.020600E-03 |
| Normal-vs-Asian |
9.4946999995571E-07 |
| Caucasian-vs-AfricanAmerican |
5.846000E-01 |
| Caucasian-vs-Asian |
8.463400E-01 |
| AfricanAmerican-vs-Asian |
5.128200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.56650256602597E-11 |
| Normal-vs-Female |
2.01640000030423E-07 |
| Male-vs-Female |
2.654100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.002660E-03 |
| Normal-vs-Age(41-60Yrs) |
6.44609920996686E-11 |
| Normal-vs-Age(61-80Yrs) |
6.9479999531552E-09 |
| Normal-vs-Age(81-100Yrs) |
1.455510E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.407360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.097400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.582400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.315000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.157000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.612800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.809000E-01 |
| Classical-VS-Follicular |
2.402000E-02 |
| Classical-VS-Other |
4.562000E-01 |
| Classical-VS-Normal |
2.21440000003348E-06 |
| Tall-VS-Follicular |
5.786600E-01 |
| Tall-VS-Other |
5.660600E-01 |
| Tall-VS-Normal |
1.67269999999942E-05 |
| Follicular-VS-Other |
7.805000E-01 |
| Follicular-VS-Normal |
2.84180001752787E-09 |
| Other-VS-Normal |
1.521150E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.90019999974412E-07 |
| Normal-vs-N1 |
4.36579994378405E-10 |
| N0-vs-N1 |
7.767600E-02 |
|
|
